FAM162A
Basic information
Region (hg38): 3:122384161-122412334
Previous symbols: [ "C3orf28" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAM162A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 2 | 0 |
Variants in FAM162A
This is a list of pathogenic ClinVar variants found in the FAM162A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-122384276-T-G | not specified | Uncertain significance (Dec 19, 2022) | ||
3-122402870-G-A | not specified | Likely benign (Mar 11, 2024) | ||
3-122404326-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
3-122404332-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
3-122407305-G-C | not specified | Uncertain significance (Dec 03, 2021) | ||
3-122407316-G-A | not specified | Uncertain significance (May 23, 2023) | ||
3-122407333-C-G | not specified | Likely benign (Aug 13, 2021) | ||
3-122407376-T-C | not specified | Uncertain significance (Jan 31, 2022) | ||
3-122409742-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
3-122409788-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
3-122409791-G-A | not specified | Uncertain significance (Nov 22, 2023) | ||
3-122409821-A-G | not specified | Uncertain significance (Jan 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FAM162A | protein_coding | protein_coding | ENST00000477892 | 5 | 28159 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000324 | 0.352 | 124608 | 1 | 179 | 124788 | 0.000721 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.599 | 68 | 83.4 | 0.815 | 0.00000432 | 996 |
Missense in Polyphen | 18 | 21.606 | 0.8331 | 266 | ||
Synonymous | 0.782 | 23 | 28.3 | 0.813 | 0.00000156 | 276 |
Loss of Function | 0.357 | 9 | 10.2 | 0.879 | 6.97e-7 | 110 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000334 | 0.000321 |
Ashkenazi Jewish | 0.0145 | 0.0138 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000213 | 0.000203 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.000102 | 0.0000980 |
Other | 0.00147 | 0.00132 |
dbNSFP
Source:
- Function
- FUNCTION: Proposed to be involved in regulation of apoptosis; the exact mechanism may differ between cell types/tissues. May be involved in hypoxia-induced cell death of transformed cells implicating cytochrome C release and caspase activation (such as CASP9) and inducing mitochondrial permeability transition. May be involved in hypoxia-induced cell death of neuronal cells probably by promoting release of AIFM1 from mitochondria to cytoplasm and its translocation to the nucleus; however, the involvement of caspases has been reported conflictingly. {ECO:0000269|PubMed:15082785}.;
Recessive Scores
- pRec
- 0.0640
Intolerance Scores
- loftool
- 0.762
- rvis_EVS
- 0.7
- rvis_percentile_EVS
- 85.42
Haploinsufficiency Scores
- pHI
- 0.0631
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0846
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fam162a
- Phenotype
Gene ontology
- Biological process
- activation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of apoptotic process;neuron apoptotic process;cellular response to hypoxia;positive regulation of release of cytochrome c from mitochondria
- Cellular component
- mitochondrion;cytosol;integral component of membrane
- Molecular function
- protein binding